Perioperative antibiotics in pediatric cardiac surgery: protocol for a systematic review

Vijay Anand1, Angela Bates2, Robin Featherstone1

  • 1University of Alberta, Edmonton, Canada.

Systematic Reviews
|June 1, 2017
PubMed

Insights

This systematic review examines prophylactic antibiotic use in pediatric cardiac surgery to address high infection rates and practice variations. Findings will inform clinical guidelines for better prevention strategies against antibiotic resistance.

Area of Science:

  • Pediatric Cardiac Surgery
  • Infectious Disease Prevention
  • Clinical Practice Guidelines

Background:

  • Post-operative infections in pediatric cardiac surgery pose a significant clinical challenge, with incidence rates ranging from 1% to 20%.
  • Current practices for perioperative antibiotic prophylaxis lack standardization regarding antibiotic choice and duration, leading to high practice variation.
  • Increasing global rates of antibiotic-resistant organisms necessitate optimized infection prevention strategies.

Purpose of the Study:

  • To systematically review evidence on prophylactic antibiotic use in pediatric cardiac surgery.
  • To identify optimal antibiotic types and durations for preventing surgical-site infections.
  • To inform the development of evidence-based clinical guidelines.

Main Methods:

  • Comprehensive search of controlled observational studies and randomized controlled trials.
  • Inclusion of data from major databases (MEDLINE, EMBASE, CENTRAL) and scientific meetings.
  • Duplicate independent data extraction, risk of bias assessment, and GRADE evaluation of evidence quality.

Main Results:

  • This section will present findings from the systematic review, detailing effective prophylactic antibiotic strategies.
  • Analysis will focus on infection rates, types of antibiotics used, and duration of administration.
  • Evidence quality will be assessed to guide recommendations.

Conclusions:

  • The systematic review will provide evidence to standardize prophylactic antibiotic use in pediatric cardiac surgery.
  • Findings will support the creation of clinical guidelines to reduce surgical-site infections and combat antibiotic resistance.
  • Dissemination through publications and conferences will promote adoption of best practices.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
403
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
341
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
233
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
392
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293
Antibiotic Selection00:57

Antibiotic Selection

Overview
61.2K